On March 16, 2022, HLS Therapeutics Inc.'s Board of Directors declared a dividend of CAD 0.05 per outstanding common share to be paid on June 15, 2022, to shareholders of record as of April 29, 2022.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
4.73 CAD | -0.42% | -3.86% | +19.75% |
Apr. 08 | HLS Therapeutics Inc. Announces Reduce-IT Analysis Results Relating the Effects of VASCEPA | CI |
Mar. 14 | Transcript : HLS Therapeutics Inc., Q4 2023 Earnings Call, Mar 14, 2024 |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+19.75% | 110M | |
+16.62% | 70.36B | |
+2.99% | 25.18B | |
+6.36% | 8.61B | |
+6.46% | 8.14B | |
-21.01% | 7.83B | |
-0.61% | 4.56B | |
+17.12% | 4.32B | |
-0.14% | 4.06B | |
-3.30% | 3.87B |
- Stock Market
- Equities
- HLS Stock
- News HLS Therapeutics Inc.
- HLS Therapeutics Inc. Declares Dividend for the Year 2021, Payable on June 15, 2022